Public Company News

Addentax Group Corp. Announces Reverse Stock Split

SHENZHEN, China, March 26, 2026 /PRNewswire/ -- Addentax Group Corp. (Nasdaq: ATXG) (the "Company") announced today that following the stockholder approval of the reverse stock split proposal at the Company's 2025 Annual Meeting of Stockholders held on January 30, 2026, the Board of Directors of ...

2026-03-26 21:00 7583

CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

Key Highlights: * Excellent Safety Profile:  As of mid-March 2026, 113 heavily pretreated patients with solid tumors have been enrolled in the Phase I trial of CS2009, with a median follow-up of approximately 6 months. The more mature data continue to show a favorable safety profile, with23% i...

2026-03-26 20:53 8365

Peijia Medical Announces 2025 Annual Results

SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its annual results for the year ended December 31, 2025 on March 25, 2026. During th...

2026-03-26 20:00 6708

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

* Reinforcing long-term commitment to embedding sustainability across operations and partnerships * Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a ...

2026-03-26 20:00 6370

Highway Holdings Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG, March 26, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today announced that on March 17, 2026,Highway Holdings Limited (the "Company") received a written notification (the "Notification Letter") from the Listing Qualifications Depart...

2026-03-26 19:00 6926

Innovent Announces 2025 Annual Results and Business Updates

From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and SUZHOU, China, March 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develop...

2026-03-26 18:00 8995

GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala

- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing process ensures superior safety profile YONGIN, South Korea, March 26, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biophar...

2026-03-26 14:23 4482

LG Leadership Emphasizes 'Speed' as the Core Driver in the AX Era

SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- LG hosted a President's Meeting on the 25th at the Namsan Leadership Center in Seoul, attended by LG Corp. Chairman and CEO Kwang-mo Koo and about 40 top executives from major affiliates. LG...

2026-03-26 13:53 5104

Hengrui Pharma Announces Strong 2025 Annual Results

SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13% year-on-year to RMB 31.63 billion, and net profit attribut...

2026-03-26 08:52 5238

Health In Tech Announces $7.0 Million Private Placement

STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") ...

2026-03-26 05:38 7150

X Financial Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

SHENZHEN, China, March 25, 2026 /PRNewswire/ -- X Financial (NYSE: XYF), a leading Chinesefintech platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. This press release should be read in conjunction with the Company's Report on...

2026-03-26 04:50 7465

OLLOBOT Prepares August Kickstarter Launch for Enhanced OlloNi Following Strong CES 2026 Debut

LAS VEGAS, March 25, 2026 /PRNewswire/ -- OLLOBOT, a brand focused on fusing advanced technology with emotional companionship, announced that the upgraded version of OlloNi, its companion‑robot concept first revealed earlier this year, is scheduled to launch on Kickstarter ...

2026-03-26 00:00 8702

RoboSense Beat Expectations, Achieved First-Ever Quarterly Profit on Strong Robotics Growth

* Achieved the first-ever quarterly net profit in Q4 2025, reaching approximately RMB 104 million, significantly exceeding market expectations. * Quarterly LiDAR sales volume for robotics and others experienced explosive growth in Q4 2025, with total shipments reaching approximately 221,200 un...

2026-03-25 22:42 6890

Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics

SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...

2026-03-25 21:01 6923

GIBO Expands GIBO Watch with "Digital Canvas" -- A Next-Generation Generative Pipeline for Short Film Creation

KUALA LUMPUR, Malaysia, March 25, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a global technology company focused on AI-driven content infrastructure, today announced the launch of the"Digital Canvas" within its GIBO Watch framework—a next-generation generative pipeline designed to em...

2026-03-25 21:00 7021

K-Beauty Manufacturer KM Pharmaceutical (KOSDAQ: 225430) Expands Global Skincare and Oral Care OEM/ODM Platform with Advanced Functional Product Portfolio

SEOUL, South Korea, March 25, 2026 /PRNewswire/ -- KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM/ODM production, is strengthening its global position by expanding into high-value functional product categori...

2026-03-25 21:00 5794

TOYO Co., Ltd Schedules Second Half and Fiscal Year 2025 Earnings Release and Conference Call Date

TOKYO, March 25, 2026 /PRNewswire/ -- TOYO Co., Ltd (NASDAQ: TOYO) (OTC: TOYWF), a solar solutions company, today announced that it will host a conference call to discuss its second half and fiscal year 2025 results on Tuesday, March 31, 2026. Conference Call Detail...

2026-03-25 20:30 6354

Erayak Strategic Roadmap: Providing a High-Precision Energy Defense Against Global Oil and Grid Volatility

Optimizing Tri-Fuel "Infinite Runtime" and Utility-Grade Power Quality to Shield Modern Households from Energy Crises WENZHOU, China, March 25, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a leading developer of ...

2026-03-25 20:05 5336

Cheche Group Schedules Second Half and FY 2025 Earnings Release and Conference Call Date

BEIJING, March 25, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss results for the Second Half and Full Year 2025 on T...

2026-03-25 20:00 5646

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics ...

2026-03-25 20:00 5644
1 ... 63646566676869 ... 753

Week's Top Stories